02/02/2026
Validated biologics. Not just clones.
India’s Biopharma SHAKTI initiative is accelerating the country’s biologics and biosimilars ecosystem. At GeNext Genomics (GNG), we’re proud to support this vision with regulatory-ready biologics, global-standard services, and end-to-end support from clone development to scalable programs.
Our strengths include a broad biosimilar portfolio, global compliance, and export-ready solutionsenabling self-reliant, innovation-driven biotech from India.
Let’s collaborate to power India’s next wave of biologics innovation.
📩 info@genextgenomics.com | 🌐 www.genextgenomics.com